Triamcinolone aminobenzal benzamidoisobutyrate
![]()  | |
| Clinical data | |
|---|---|
| Trade names | Taucorten | 
| Other names | TBI-PAB; TBI/PAB; Tbi-Pab; 16α,17α-(4-Dimethylamino-  benzyliden)triamcinolone 21-(β-benzoylamino)isobutyrate; 21-(3-(benzoylamino)-2-methyl-1-oxopropoxy)-16α,17α-(((4-(dimethylamino)phenyl)- methylene)bis(oxy))-9α-fluoro-11β-hydroxypregna-1,4-diene-3,20-dione  | 
| Drug class | Corticosteroid; Glucocorticoid | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C41H47FN2O8 | 
| Molar mass | 714.831 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
Triamcinolone aminobenzal benzamidoisobutyrate (TBI-PAB; brand name Taucorten) is a synthetic glucocorticoid corticosteroid which is no longer marketed.[1][2]
References
- ↑ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1228–. ISBN 978-1-4757-2085-3.
 - ↑ Martindale W, Royal Pharmaceutical Society of Great Britain. Dept. of Pharmaceutical Sciences (1993). The Extra Pharmacopoeia. Pharmaceutical Press. p. 740. ISBN 978-0-85369-300-0.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
